Cargando…

Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status

BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known....

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuno, Muneaki, Ueno, Yuji, Takekawa, Hidehiro, Kanemaru, Kodai, Shimizu, Takahiro, Kuriki, Ayako, Tateishi, Yohei, Doijiri, Ryosuke, Shimada, Yoshiaki, Yamaguchi, Eriko, Koga, Masatoshi, Kamiya, Yuki, Ihara, Masafumi, Tsujino, Akira, Hirata, Koichi, Hasegawa, Yasuhiro, Aizawa, Hitoshi, Hattori, Nobutaka, Urabe, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751843/
https://www.ncbi.nlm.nih.gov/pubmed/34689573
http://dx.doi.org/10.1161/JAHA.120.021375
_version_ 1784631762364661760
author Kikuno, Muneaki
Ueno, Yuji
Takekawa, Hidehiro
Kanemaru, Kodai
Shimizu, Takahiro
Kuriki, Ayako
Tateishi, Yohei
Doijiri, Ryosuke
Shimada, Yoshiaki
Yamaguchi, Eriko
Koga, Masatoshi
Kamiya, Yuki
Ihara, Masafumi
Tsujino, Akira
Hirata, Koichi
Hasegawa, Yasuhiro
Aizawa, Hitoshi
Hattori, Nobutaka
Urabe, Takao
author_facet Kikuno, Muneaki
Ueno, Yuji
Takekawa, Hidehiro
Kanemaru, Kodai
Shimizu, Takahiro
Kuriki, Ayako
Tateishi, Yohei
Doijiri, Ryosuke
Shimada, Yoshiaki
Yamaguchi, Eriko
Koga, Masatoshi
Kamiya, Yuki
Ihara, Masafumi
Tsujino, Akira
Hirata, Koichi
Hasegawa, Yasuhiro
Aizawa, Hitoshi
Hattori, Nobutaka
Urabe, Takao
author_sort Kikuno, Muneaki
collection PubMed
description BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known. The aim of this study was to elucidate the different underlying pathogeneses of cryptogenic stroke in active and inactive patients with cancer, with detailed investigation by transesophageal echocardiography. METHODS AND RESULTS: CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for Embolic Stroke of Undetermined Source/Cryptogenic Stroke) registry is a multicenter registry including data of patients initially diagnosed as having cryptogenic stroke and undergoing transesophageal echocardiography. Patients were divided into active cancer, inactive cancer, and noncancer groups, and their clinical features were compared. Of the total 667 enrolled patients (age, 68.7±12.8 years; 455 men), 41 (6.1%) had active cancer, and 51 (7.5%) had a history of inactive cancer. On multinomial logistic regression analysis, infarctions in multiple vascular territories (odds ratio [OR], 2.73; 95% CI, 1.39–5.40) and CRP (C‐reactive protein) (OR, 1.10; 95% CI, 1.01–1.19) were independently associated with active cancer, whereas age (OR, 1.05; 95% CI, 1.01–1.08), contralateral carotid stenosis from the index stroke lesion (OR, 4.05; 95% CI, 1.60–10.27), calcification of the aortic valve (OR, 2.10; 95% CI, 1.09–4.05), and complicated lesion of the aortic arch (OR, 2.13; 95% CI, 1.11–4.10) were significantly associated with inactive cancer. CONCLUSIONS: Patients with cancer were not rare in cryptogenic stroke. Although patients with active cancer had more multiple infarctions, patients with inactive cancer had more atherosclerotic embolic sources potentially causing arteriogenic strokes. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000032957.
format Online
Article
Text
id pubmed-8751843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87518432022-01-14 Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status Kikuno, Muneaki Ueno, Yuji Takekawa, Hidehiro Kanemaru, Kodai Shimizu, Takahiro Kuriki, Ayako Tateishi, Yohei Doijiri, Ryosuke Shimada, Yoshiaki Yamaguchi, Eriko Koga, Masatoshi Kamiya, Yuki Ihara, Masafumi Tsujino, Akira Hirata, Koichi Hasegawa, Yasuhiro Aizawa, Hitoshi Hattori, Nobutaka Urabe, Takao J Am Heart Assoc Original Research BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known. The aim of this study was to elucidate the different underlying pathogeneses of cryptogenic stroke in active and inactive patients with cancer, with detailed investigation by transesophageal echocardiography. METHODS AND RESULTS: CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for Embolic Stroke of Undetermined Source/Cryptogenic Stroke) registry is a multicenter registry including data of patients initially diagnosed as having cryptogenic stroke and undergoing transesophageal echocardiography. Patients were divided into active cancer, inactive cancer, and noncancer groups, and their clinical features were compared. Of the total 667 enrolled patients (age, 68.7±12.8 years; 455 men), 41 (6.1%) had active cancer, and 51 (7.5%) had a history of inactive cancer. On multinomial logistic regression analysis, infarctions in multiple vascular territories (odds ratio [OR], 2.73; 95% CI, 1.39–5.40) and CRP (C‐reactive protein) (OR, 1.10; 95% CI, 1.01–1.19) were independently associated with active cancer, whereas age (OR, 1.05; 95% CI, 1.01–1.08), contralateral carotid stenosis from the index stroke lesion (OR, 4.05; 95% CI, 1.60–10.27), calcification of the aortic valve (OR, 2.10; 95% CI, 1.09–4.05), and complicated lesion of the aortic arch (OR, 2.13; 95% CI, 1.11–4.10) were significantly associated with inactive cancer. CONCLUSIONS: Patients with cancer were not rare in cryptogenic stroke. Although patients with active cancer had more multiple infarctions, patients with inactive cancer had more atherosclerotic embolic sources potentially causing arteriogenic strokes. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000032957. John Wiley and Sons Inc. 2021-10-23 /pmc/articles/PMC8751843/ /pubmed/34689573 http://dx.doi.org/10.1161/JAHA.120.021375 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Kikuno, Muneaki
Ueno, Yuji
Takekawa, Hidehiro
Kanemaru, Kodai
Shimizu, Takahiro
Kuriki, Ayako
Tateishi, Yohei
Doijiri, Ryosuke
Shimada, Yoshiaki
Yamaguchi, Eriko
Koga, Masatoshi
Kamiya, Yuki
Ihara, Masafumi
Tsujino, Akira
Hirata, Koichi
Hasegawa, Yasuhiro
Aizawa, Hitoshi
Hattori, Nobutaka
Urabe, Takao
Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title_full Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title_fullStr Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title_full_unstemmed Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title_short Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
title_sort distinction in prevalence of atherosclerotic embolic sources in cryptogenic stroke with cancer status
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751843/
https://www.ncbi.nlm.nih.gov/pubmed/34689573
http://dx.doi.org/10.1161/JAHA.120.021375
work_keys_str_mv AT kikunomuneaki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT uenoyuji distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT takekawahidehiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT kanemarukodai distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT shimizutakahiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT kurikiayako distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT tateishiyohei distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT doijiriryosuke distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT shimadayoshiaki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT yamaguchieriko distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT kogamasatoshi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT kamiyayuki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT iharamasafumi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT tsujinoakira distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT hiratakoichi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT hasegawayasuhiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT aizawahitoshi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT hattorinobutaka distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT urabetakao distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus
AT distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus